Global Infliximab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Infliximab Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Infliximab injection is an antibody drug composed of chimeric monoclonal antibodies. It reduces inflammatory responses by inhibiting the activity of TNF-? and is used to treat a variety of chronic inflammatory diseases.
This report is a detailed and comprehensive analysis for global Infliximab Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infliximab Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Infliximab Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Infliximab Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Infliximab Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infliximab Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infliximab Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, Ayumi Pharmaceuticals, Pfizer, Nichiiko, Nippon Kayaku, AMGEN, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Infliximab Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Infliximab Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Infliximab Injection, with price, sales quantity, revenue, and global market share of Infliximab Injection from 2021 to 2026.
Chapter 3, the Infliximab Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infliximab Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Infliximab Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Infliximab Injection.
Chapter 14 and 15, to describe Infliximab Injection sales channel, distributors, customers, research findings and conclusion.
Infliximab injection is an antibody drug composed of chimeric monoclonal antibodies. It reduces inflammatory responses by inhibiting the activity of TNF-? and is used to treat a variety of chronic inflammatory diseases.
This report is a detailed and comprehensive analysis for global Infliximab Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infliximab Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Infliximab Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Infliximab Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Infliximab Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infliximab Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infliximab Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, Ayumi Pharmaceuticals, Pfizer, Nichiiko, Nippon Kayaku, AMGEN, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Infliximab Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Original Drug
- Generic Drug
- Hospital
- Clinic
- Other
- Celltrion
- Janssen Biologics
- Hangzhou Bozhirui Biopharmaceuticals
- Taizhou Maiboteike Pharmaceuticals
- Yuxi Jiahe Biotechnology
- Ayumi Pharmaceuticals
- Pfizer
- Nichiiko
- Nippon Kayaku
- AMGEN
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Infliximab Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Infliximab Injection, with price, sales quantity, revenue, and global market share of Infliximab Injection from 2021 to 2026.
Chapter 3, the Infliximab Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infliximab Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Infliximab Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Infliximab Injection.
Chapter 14 and 15, to describe Infliximab Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Infliximab Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Infliximab Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Infliximab Injection Market Size & Forecast
1.5.1 Global Infliximab Injection Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Infliximab Injection Sales Quantity (2021-2032)
1.5.3 Global Infliximab Injection Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Celltrion
2.1.1 Celltrion Details
2.1.2 Celltrion Major Business
2.1.3 Celltrion Infliximab Injection Product and Services
2.1.4 Celltrion Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Celltrion Recent Developments/Updates
2.2 Janssen Biologics
2.2.1 Janssen Biologics Details
2.2.2 Janssen Biologics Major Business
2.2.3 Janssen Biologics Infliximab Injection Product and Services
2.2.4 Janssen Biologics Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Janssen Biologics Recent Developments/Updates
2.3 Hangzhou Bozhirui Biopharmaceuticals
2.3.1 Hangzhou Bozhirui Biopharmaceuticals Details
2.3.2 Hangzhou Bozhirui Biopharmaceuticals Major Business
2.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product and Services
2.3.4 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
2.4 Taizhou Maiboteike Pharmaceuticals
2.4.1 Taizhou Maiboteike Pharmaceuticals Details
2.4.2 Taizhou Maiboteike Pharmaceuticals Major Business
2.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product and Services
2.4.4 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
2.5 Yuxi Jiahe Biotechnology
2.5.1 Yuxi Jiahe Biotechnology Details
2.5.2 Yuxi Jiahe Biotechnology Major Business
2.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Product and Services
2.5.4 Yuxi Jiahe Biotechnology Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yuxi Jiahe Biotechnology Recent Developments/Updates
2.6 Ayumi Pharmaceuticals
2.6.1 Ayumi Pharmaceuticals Details
2.6.2 Ayumi Pharmaceuticals Major Business
2.6.3 Ayumi Pharmaceuticals Infliximab Injection Product and Services
2.6.4 Ayumi Pharmaceuticals Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Ayumi Pharmaceuticals Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Infliximab Injection Product and Services
2.7.4 Pfizer Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Pfizer Recent Developments/Updates
2.8 Nichiiko
2.8.1 Nichiiko Details
2.8.2 Nichiiko Major Business
2.8.3 Nichiiko Infliximab Injection Product and Services
2.8.4 Nichiiko Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Nichiiko Recent Developments/Updates
2.9 Nippon Kayaku
2.9.1 Nippon Kayaku Details
2.9.2 Nippon Kayaku Major Business
2.9.3 Nippon Kayaku Infliximab Injection Product and Services
2.9.4 Nippon Kayaku Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Nippon Kayaku Recent Developments/Updates
2.10 AMGEN
2.10.1 AMGEN Details
2.10.2 AMGEN Major Business
2.10.3 AMGEN Infliximab Injection Product and Services
2.10.4 AMGEN Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 AMGEN Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLIXIMAB INJECTION BY MANUFACTURER
3.1 Global Infliximab Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Infliximab Injection Revenue by Manufacturer (2021-2026)
3.3 Global Infliximab Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Infliximab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Infliximab Injection Manufacturer Market Share in 2025
3.4.3 Top 6 Infliximab Injection Manufacturer Market Share in 2025
3.5 Infliximab Injection Market: Overall Company Footprint Analysis
3.5.1 Infliximab Injection Market: Region Footprint
3.5.2 Infliximab Injection Market: Company Product Type Footprint
3.5.3 Infliximab Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Infliximab Injection Market Size by Region
4.1.1 Global Infliximab Injection Sales Quantity by Region (2021-2032)
4.1.2 Global Infliximab Injection Consumption Value by Region (2021-2032)
4.1.3 Global Infliximab Injection Average Price by Region (2021-2032)
4.2 North America Infliximab Injection Consumption Value (2021-2032)
4.3 Europe Infliximab Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Infliximab Injection Consumption Value (2021-2032)
4.5 South America Infliximab Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Infliximab Injection Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Infliximab Injection Sales Quantity by Type (2021-2032)
5.2 Global Infliximab Injection Consumption Value by Type (2021-2032)
5.3 Global Infliximab Injection Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Infliximab Injection Sales Quantity by Application (2021-2032)
6.2 Global Infliximab Injection Consumption Value by Application (2021-2032)
6.3 Global Infliximab Injection Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Infliximab Injection Sales Quantity by Type (2021-2032)
7.2 North America Infliximab Injection Sales Quantity by Application (2021-2032)
7.3 North America Infliximab Injection Market Size by Country
7.3.1 North America Infliximab Injection Sales Quantity by Country (2021-2032)
7.3.2 North America Infliximab Injection Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Infliximab Injection Sales Quantity by Type (2021-2032)
8.2 Europe Infliximab Injection Sales Quantity by Application (2021-2032)
8.3 Europe Infliximab Injection Market Size by Country
8.3.1 Europe Infliximab Injection Sales Quantity by Country (2021-2032)
8.3.2 Europe Infliximab Injection Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Infliximab Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Infliximab Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Infliximab Injection Market Size by Region
9.3.1 Asia-Pacific Infliximab Injection Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Infliximab Injection Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Infliximab Injection Sales Quantity by Type (2021-2032)
10.2 South America Infliximab Injection Sales Quantity by Application (2021-2032)
10.3 South America Infliximab Injection Market Size by Country
10.3.1 South America Infliximab Injection Sales Quantity by Country (2021-2032)
10.3.2 South America Infliximab Injection Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Infliximab Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Infliximab Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Infliximab Injection Market Size by Country
11.3.1 Middle East & Africa Infliximab Injection Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Infliximab Injection Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Infliximab Injection Market Drivers
12.2 Infliximab Injection Market Restraints
12.3 Infliximab Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Infliximab Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Infliximab Injection
13.3 Infliximab Injection Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Infliximab Injection Typical Distributors
14.3 Infliximab Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Infliximab Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Infliximab Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Infliximab Injection Market Size & Forecast
1.5.1 Global Infliximab Injection Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Infliximab Injection Sales Quantity (2021-2032)
1.5.3 Global Infliximab Injection Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Celltrion
2.1.1 Celltrion Details
2.1.2 Celltrion Major Business
2.1.3 Celltrion Infliximab Injection Product and Services
2.1.4 Celltrion Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Celltrion Recent Developments/Updates
2.2 Janssen Biologics
2.2.1 Janssen Biologics Details
2.2.2 Janssen Biologics Major Business
2.2.3 Janssen Biologics Infliximab Injection Product and Services
2.2.4 Janssen Biologics Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Janssen Biologics Recent Developments/Updates
2.3 Hangzhou Bozhirui Biopharmaceuticals
2.3.1 Hangzhou Bozhirui Biopharmaceuticals Details
2.3.2 Hangzhou Bozhirui Biopharmaceuticals Major Business
2.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product and Services
2.3.4 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
2.4 Taizhou Maiboteike Pharmaceuticals
2.4.1 Taizhou Maiboteike Pharmaceuticals Details
2.4.2 Taizhou Maiboteike Pharmaceuticals Major Business
2.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product and Services
2.4.4 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
2.5 Yuxi Jiahe Biotechnology
2.5.1 Yuxi Jiahe Biotechnology Details
2.5.2 Yuxi Jiahe Biotechnology Major Business
2.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Product and Services
2.5.4 Yuxi Jiahe Biotechnology Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yuxi Jiahe Biotechnology Recent Developments/Updates
2.6 Ayumi Pharmaceuticals
2.6.1 Ayumi Pharmaceuticals Details
2.6.2 Ayumi Pharmaceuticals Major Business
2.6.3 Ayumi Pharmaceuticals Infliximab Injection Product and Services
2.6.4 Ayumi Pharmaceuticals Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Ayumi Pharmaceuticals Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Infliximab Injection Product and Services
2.7.4 Pfizer Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Pfizer Recent Developments/Updates
2.8 Nichiiko
2.8.1 Nichiiko Details
2.8.2 Nichiiko Major Business
2.8.3 Nichiiko Infliximab Injection Product and Services
2.8.4 Nichiiko Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Nichiiko Recent Developments/Updates
2.9 Nippon Kayaku
2.9.1 Nippon Kayaku Details
2.9.2 Nippon Kayaku Major Business
2.9.3 Nippon Kayaku Infliximab Injection Product and Services
2.9.4 Nippon Kayaku Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Nippon Kayaku Recent Developments/Updates
2.10 AMGEN
2.10.1 AMGEN Details
2.10.2 AMGEN Major Business
2.10.3 AMGEN Infliximab Injection Product and Services
2.10.4 AMGEN Infliximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 AMGEN Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLIXIMAB INJECTION BY MANUFACTURER
3.1 Global Infliximab Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Infliximab Injection Revenue by Manufacturer (2021-2026)
3.3 Global Infliximab Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Infliximab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Infliximab Injection Manufacturer Market Share in 2025
3.4.3 Top 6 Infliximab Injection Manufacturer Market Share in 2025
3.5 Infliximab Injection Market: Overall Company Footprint Analysis
3.5.1 Infliximab Injection Market: Region Footprint
3.5.2 Infliximab Injection Market: Company Product Type Footprint
3.5.3 Infliximab Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Infliximab Injection Market Size by Region
4.1.1 Global Infliximab Injection Sales Quantity by Region (2021-2032)
4.1.2 Global Infliximab Injection Consumption Value by Region (2021-2032)
4.1.3 Global Infliximab Injection Average Price by Region (2021-2032)
4.2 North America Infliximab Injection Consumption Value (2021-2032)
4.3 Europe Infliximab Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Infliximab Injection Consumption Value (2021-2032)
4.5 South America Infliximab Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Infliximab Injection Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Infliximab Injection Sales Quantity by Type (2021-2032)
5.2 Global Infliximab Injection Consumption Value by Type (2021-2032)
5.3 Global Infliximab Injection Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Infliximab Injection Sales Quantity by Application (2021-2032)
6.2 Global Infliximab Injection Consumption Value by Application (2021-2032)
6.3 Global Infliximab Injection Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Infliximab Injection Sales Quantity by Type (2021-2032)
7.2 North America Infliximab Injection Sales Quantity by Application (2021-2032)
7.3 North America Infliximab Injection Market Size by Country
7.3.1 North America Infliximab Injection Sales Quantity by Country (2021-2032)
7.3.2 North America Infliximab Injection Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Infliximab Injection Sales Quantity by Type (2021-2032)
8.2 Europe Infliximab Injection Sales Quantity by Application (2021-2032)
8.3 Europe Infliximab Injection Market Size by Country
8.3.1 Europe Infliximab Injection Sales Quantity by Country (2021-2032)
8.3.2 Europe Infliximab Injection Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Infliximab Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Infliximab Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Infliximab Injection Market Size by Region
9.3.1 Asia-Pacific Infliximab Injection Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Infliximab Injection Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Infliximab Injection Sales Quantity by Type (2021-2032)
10.2 South America Infliximab Injection Sales Quantity by Application (2021-2032)
10.3 South America Infliximab Injection Market Size by Country
10.3.1 South America Infliximab Injection Sales Quantity by Country (2021-2032)
10.3.2 South America Infliximab Injection Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Infliximab Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Infliximab Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Infliximab Injection Market Size by Country
11.3.1 Middle East & Africa Infliximab Injection Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Infliximab Injection Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Infliximab Injection Market Drivers
12.2 Infliximab Injection Market Restraints
12.3 Infliximab Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Infliximab Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Infliximab Injection
13.3 Infliximab Injection Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Infliximab Injection Typical Distributors
14.3 Infliximab Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Infliximab Injection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Infliximab Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Celltrion Basic Information, Manufacturing Base and Competitors
Table 4. Celltrion Major Business
Table 5. Celltrion Infliximab Injection Product and Services
Table 6. Celltrion Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Celltrion Recent Developments/Updates
Table 8. Janssen Biologics Basic Information, Manufacturing Base and Competitors
Table 9. Janssen Biologics Major Business
Table 10. Janssen Biologics Infliximab Injection Product and Services
Table 11. Janssen Biologics Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Janssen Biologics Recent Developments/Updates
Table 13. Hangzhou Bozhirui Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Hangzhou Bozhirui Biopharmaceuticals Major Business
Table 15. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product and Services
Table 16. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
Table 18. Taizhou Maiboteike Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Taizhou Maiboteike Pharmaceuticals Major Business
Table 20. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product and Services
Table 21. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
Table 23. Yuxi Jiahe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Yuxi Jiahe Biotechnology Major Business
Table 25. Yuxi Jiahe Biotechnology Infliximab Injection Product and Services
Table 26. Yuxi Jiahe Biotechnology Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Yuxi Jiahe Biotechnology Recent Developments/Updates
Table 28. Ayumi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Ayumi Pharmaceuticals Major Business
Table 30. Ayumi Pharmaceuticals Infliximab Injection Product and Services
Table 31. Ayumi Pharmaceuticals Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Ayumi Pharmaceuticals Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Infliximab Injection Product and Services
Table 36. Pfizer Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Pfizer Recent Developments/Updates
Table 38. Nichiiko Basic Information, Manufacturing Base and Competitors
Table 39. Nichiiko Major Business
Table 40. Nichiiko Infliximab Injection Product and Services
Table 41. Nichiiko Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Nichiiko Recent Developments/Updates
Table 43. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 44. Nippon Kayaku Major Business
Table 45. Nippon Kayaku Infliximab Injection Product and Services
Table 46. Nippon Kayaku Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Nippon Kayaku Recent Developments/Updates
Table 48. AMGEN Basic Information, Manufacturing Base and Competitors
Table 49. AMGEN Major Business
Table 50. AMGEN Infliximab Injection Product and Services
Table 51. AMGEN Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. AMGEN Recent Developments/Updates
Table 53. Global Infliximab Injection Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 54. Global Infliximab Injection Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global Infliximab Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 56. Market Position of Manufacturers in Infliximab Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and Infliximab Injection Production Site of Key Manufacturer
Table 58. Infliximab Injection Market: Company Product Type Footprint
Table 59. Infliximab Injection Market: Company Product Application Footprint
Table 60. Infliximab Injection New Market Entrants and Barriers to Market Entry
Table 61. Infliximab Injection Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Infliximab Injection Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global Infliximab Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 64. Global Infliximab Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 65. Global Infliximab Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global Infliximab Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global Infliximab Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 68. Global Infliximab Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 69. Global Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 70. Global Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 71. Global Infliximab Injection Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global Infliximab Injection Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global Infliximab Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 74. Global Infliximab Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 75. Global Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 76. Global Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 77. Global Infliximab Injection Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global Infliximab Injection Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global Infliximab Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 80. Global Infliximab Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 81. North America Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 82. North America Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 83. North America Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 84. North America Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 85. North America Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 86. North America Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 87. North America Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 90. Europe Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 91. Europe Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 92. Europe Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 93. Europe Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 94. Europe Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 95. Europe Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 99. Asia-Pacific Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 101. Asia-Pacific Infliximab Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Infliximab Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 103. Asia-Pacific Infliximab Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Infliximab Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 106. South America Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 107. South America Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 108. South America Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 109. South America Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 110. South America Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 111. South America Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 115. Middle East & Africa Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 117. Middle East & Africa Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 119. Middle East & Africa Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Infliximab Injection Raw Material
Table 122. Key Manufacturers of Infliximab Injection Raw Materials
Table 123. Infliximab Injection Typical Distributors
Table 124. Infliximab Injection Typical Customers
Table 1. Global Infliximab Injection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Infliximab Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Celltrion Basic Information, Manufacturing Base and Competitors
Table 4. Celltrion Major Business
Table 5. Celltrion Infliximab Injection Product and Services
Table 6. Celltrion Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Celltrion Recent Developments/Updates
Table 8. Janssen Biologics Basic Information, Manufacturing Base and Competitors
Table 9. Janssen Biologics Major Business
Table 10. Janssen Biologics Infliximab Injection Product and Services
Table 11. Janssen Biologics Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Janssen Biologics Recent Developments/Updates
Table 13. Hangzhou Bozhirui Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Hangzhou Bozhirui Biopharmaceuticals Major Business
Table 15. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product and Services
Table 16. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
Table 18. Taizhou Maiboteike Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Taizhou Maiboteike Pharmaceuticals Major Business
Table 20. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product and Services
Table 21. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
Table 23. Yuxi Jiahe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Yuxi Jiahe Biotechnology Major Business
Table 25. Yuxi Jiahe Biotechnology Infliximab Injection Product and Services
Table 26. Yuxi Jiahe Biotechnology Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Yuxi Jiahe Biotechnology Recent Developments/Updates
Table 28. Ayumi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Ayumi Pharmaceuticals Major Business
Table 30. Ayumi Pharmaceuticals Infliximab Injection Product and Services
Table 31. Ayumi Pharmaceuticals Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Ayumi Pharmaceuticals Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Infliximab Injection Product and Services
Table 36. Pfizer Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Pfizer Recent Developments/Updates
Table 38. Nichiiko Basic Information, Manufacturing Base and Competitors
Table 39. Nichiiko Major Business
Table 40. Nichiiko Infliximab Injection Product and Services
Table 41. Nichiiko Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Nichiiko Recent Developments/Updates
Table 43. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 44. Nippon Kayaku Major Business
Table 45. Nippon Kayaku Infliximab Injection Product and Services
Table 46. Nippon Kayaku Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Nippon Kayaku Recent Developments/Updates
Table 48. AMGEN Basic Information, Manufacturing Base and Competitors
Table 49. AMGEN Major Business
Table 50. AMGEN Infliximab Injection Product and Services
Table 51. AMGEN Infliximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. AMGEN Recent Developments/Updates
Table 53. Global Infliximab Injection Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 54. Global Infliximab Injection Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global Infliximab Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 56. Market Position of Manufacturers in Infliximab Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and Infliximab Injection Production Site of Key Manufacturer
Table 58. Infliximab Injection Market: Company Product Type Footprint
Table 59. Infliximab Injection Market: Company Product Application Footprint
Table 60. Infliximab Injection New Market Entrants and Barriers to Market Entry
Table 61. Infliximab Injection Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Infliximab Injection Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global Infliximab Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 64. Global Infliximab Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 65. Global Infliximab Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global Infliximab Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global Infliximab Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 68. Global Infliximab Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 69. Global Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 70. Global Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 71. Global Infliximab Injection Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global Infliximab Injection Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global Infliximab Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 74. Global Infliximab Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 75. Global Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 76. Global Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 77. Global Infliximab Injection Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global Infliximab Injection Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global Infliximab Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 80. Global Infliximab Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 81. North America Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 82. North America Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 83. North America Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 84. North America Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 85. North America Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 86. North America Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 87. North America Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 90. Europe Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 91. Europe Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 92. Europe Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 93. Europe Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 94. Europe Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 95. Europe Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 99. Asia-Pacific Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 101. Asia-Pacific Infliximab Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Infliximab Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 103. Asia-Pacific Infliximab Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Infliximab Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 106. South America Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 107. South America Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 108. South America Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 109. South America Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 110. South America Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 111. South America Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Infliximab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Infliximab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 115. Middle East & Africa Infliximab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Infliximab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 117. Middle East & Africa Infliximab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Infliximab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 119. Middle East & Africa Infliximab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Infliximab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Infliximab Injection Raw Material
Table 122. Key Manufacturers of Infliximab Injection Raw Materials
Table 123. Infliximab Injection Typical Distributors
Table 124. Infliximab Injection Typical Customers
LIST OF FIGURES
Figure 1. Infliximab Injection Picture
Figure 2. Global Infliximab Injection Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Infliximab Injection Revenue Market Share by Type in 2025
Figure 4. Original Drug Examples
Figure 5. Generic Drug Examples
Figure 6. Global Infliximab Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Infliximab Injection Revenue Market Share by Application in 2025
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Infliximab Injection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Infliximab Injection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Infliximab Injection Sales Quantity (2021-2032) & (K Units)
Figure 14. Global Infliximab Injection Price (2021-2032) & (US$/Unit)
Figure 15. Global Infliximab Injection Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Infliximab Injection Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Infliximab Injection by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Infliximab Injection Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Infliximab Injection Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Infliximab Injection Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Infliximab Injection Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Infliximab Injection Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Infliximab Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Infliximab Injection Revenue Market Share by Application (2021-2032)
Figure 32. Global Infliximab Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 45. France Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Infliximab Injection Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Infliximab Injection Consumption Value Market Share by Region (2021-2032)
Figure 53. China Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 56. India Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 73. Infliximab Injection Market Drivers
Figure 74. Infliximab Injection Market Restraints
Figure 75. Infliximab Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Infliximab Injection in 2025
Figure 78. Manufacturing Process Analysis of Infliximab Injection
Figure 79. Infliximab Injection Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Infliximab Injection Picture
Figure 2. Global Infliximab Injection Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Infliximab Injection Revenue Market Share by Type in 2025
Figure 4. Original Drug Examples
Figure 5. Generic Drug Examples
Figure 6. Global Infliximab Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Infliximab Injection Revenue Market Share by Application in 2025
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Infliximab Injection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Infliximab Injection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Infliximab Injection Sales Quantity (2021-2032) & (K Units)
Figure 14. Global Infliximab Injection Price (2021-2032) & (US$/Unit)
Figure 15. Global Infliximab Injection Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Infliximab Injection Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Infliximab Injection by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Infliximab Injection Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Infliximab Injection Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Infliximab Injection Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Infliximab Injection Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Infliximab Injection Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Infliximab Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Infliximab Injection Revenue Market Share by Application (2021-2032)
Figure 32. Global Infliximab Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 45. France Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Infliximab Injection Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Infliximab Injection Consumption Value Market Share by Region (2021-2032)
Figure 53. China Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 56. India Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Infliximab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Infliximab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Infliximab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Infliximab Injection Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Infliximab Injection Consumption Value (2021-2032) & (USD Million)
Figure 73. Infliximab Injection Market Drivers
Figure 74. Infliximab Injection Market Restraints
Figure 75. Infliximab Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Infliximab Injection in 2025
Figure 78. Manufacturing Process Analysis of Infliximab Injection
Figure 79. Infliximab Injection Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
